July 20, 2022
13:00 – 15:00 CEST
IABS is a non-for-profit organisation that brings together academia, authority regulators and industry to discuss challenging projects.
Next Generation Sequencing (NGS) is such a project. It is a new technique that might replace a number of time consuming and costly viral testing, and time consuming, to show the absence of adventitious agents.
In Washington, September 28-29, the 3rd IABS NGS meeting will take place to discuss the implementation of these new techniques in detecting adventitious agents in the production and development of new and old vaccines.
However, not everyone is familiar with NGS and therefore IABS together with DCVMN decided to organise a webinar to give an introduction on NGS, in fact to initiate people not aware of these new techniques in order to understand the topics being discussed at the September meeting to implement these money and time saving techniques.
This is an invitation for people working in the field of vaccine production and development that are not aware of these new techniques and want to learn more about it to improve the production and development of their vaccines.
This is a collaboration between IABS and DCMN to improve knowledge of new techniques.
Agenda
13:00-13:05 | Welcome | Pieter Neels – IABS |
13:05-13:25 |
Introduction to NGS Burning questions |
Sebastiaan Theuns – PathoSense |
13:30-13:50 |
EDQM achievements and perspectives on Next Generation Sequencing Burning questions |
Laurent Mallet – EDQM Gwenael Cirefice – EDQM |
12:55-14:15 |
Reference Materials for NGS Burning questions |
Arifa Khan – FDA |
14:20-14:40 | NGS at WHO/ECBS/NIBSC | To be confirmed |
14:40-15:00 | Questions | All |
Speakers
Pieter Neels – IABS
Sebastiaan Theuns – PathoSense
Laurent Mallet – EDQM
Gwenael Cirefice – EDQM
Arifa Khan – FDA
WHO representative -To be confirmed